Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IGENE Biotechnology was a Maryland-based biotechnology firm focused on the commercialization of specialty chemicals produced via fermentation. The company's flagship product, AstaX, is a natural source of astaxanthin derived from the yeast Phaffia rhodozyma, used extensively in the aquaculture industry to pigment salmonids. Beyond aquaculture, IGENE developed fermentation-based solutions for the food, feed, and agricultural sectors. The company operated as a pioneer in the production of high-value carotenoids through microbial processes rather than synthetic chemistry. In 2011, IGENE was fully acquired by Archer Daniels Midland (ADM), which integrated the technology into its specialty feed ingredients business.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IGENE Biotechnology.